Full-Time

Senior Medical Representative

Respiratory

Confirmed live in the last 24 hours

Deadline 7/11/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior

Abu Dhabi - United Arab Emirates

In Person

Only applications based in UAE will be considered.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Sales
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in pharmaceutical science
  • Previous experience in the pharmaceutical or healthcare industry more than 2 year
  • Comprehensive understanding of the commercial pharmaceutical marketplace
  • Proven Project Management skills
  • Outstanding selling skills
  • Expertise in using Microsoft Excel and Microsoft PowerPoint
  • Planning and organization skills
  • Impactful presentation skills
  • Fluency in English
Responsibilities
  • Engage primary care healthcare professionals in dialogue about approved indications and product efficacy/safety profiles to support on-label prescribing for appropriate patients.
  • Work with Sales Manager to develop a local strategy and business plan to meet or exceed sales and call execution goals in the territory
  • Drive sales performance and ensure sales forecasts and assigned budgets meet or exceed therapeutic and territory expectations
  • Develop and maintain in-depth knowledge of the market, demographic, and managed market’s information relative to assigned sales territory
  • Comply with all regulations regarding interactions with healthcare professionals, distribution of samples, etc.
  • Ensure excellent medical knowledge and promotional skills related to his/her disease area and product
Desired Qualifications
  • Previous experience in the Respiratory therapy area
  • Previous experience in Abu Dhabi accounts
  • Preferably has experience in NMC Group

AstraZeneca focuses on discovering, developing, and selling prescription medicines, primarily in three areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are developed through extensive research and development, which includes rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AstraZeneca's AI partnership with Sheffield enhances protein folding and drug discovery.
  • The expansion in Bangalore creates 400 jobs, boosting AstraZeneca's global operations.
  • Strategic stake in Niox Group offers collaboration opportunities in the pharmaceutical sector.

What critics are saying

  • Expansion in Bangalore may face challenges from local regulatory changes.
  • Stake in Niox Group exposes AstraZeneca to financial risks if Niox underperforms.
  • CSPC collaboration may be affected by geopolitical tensions or trade restrictions.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

HRKatha
Jun 27th, 2025
AstraZeneca creates 400 jobs, expands its global hub in Bangalore

AstraZeneca creates 400 jobs, expands its global hub in Bangalore.

Devdiscourse
Jun 18th, 2025
AstraZeneca's Stake in Niox Group: A Strategic Partnership | Headlines

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move signals strategic collaboration opportunities between the two companies, potentially aligning their interests in the pharmaceutical industry and expanding their influence in the sector.

InfBusiness
Jun 17th, 2025
Scientists present AI solution for protein folding

Scientists from the University of Sheffield, in partnership with AstraZeneca, have developed an artificial intelligence system called MapDiff, which allows for more efficient creation of proteins with a giventhree-dimensional structure and biological functions.

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC

Cision
Jun 6th, 2025
Fixed-Duration Calquence Approved In Eu For 1L Cll

Fixed-duration Calquence approved in EU for 1L CLL